#pancreaticcancer is a deadly disease. New #trial data shows early benefits for addition of a personalized #mRNA #vaccine to #adjuvantchemotherapy after resection of the tumor. This feature in Deutsche Welle discusses the implications with Nina Bhardwaj and Drew Weissman #Immunotherapy #oncology https://t.co/j81AOXjcJS
Follow
@halama_immuno One small detail I like about this trial is that they used to Covid vaccine as a positive control for immune competence
@cyrilpedia Actually there is also an jnteresting aspect in terms of immune stimulation through the COVID vaccine per se in #cancer patients...which might lead to other combinatorial approaches... #immunology